The impact of type 2 diabetes mellitus on the clinical profile, myocardial fibrosis, and prognosis in non-ischemic dilated cardiomyopathy: a prospective cohort study.

Authors:
Li Y; Xian H; Xu Y; Li W; Guo J and 7 more

Journal:
Cardiovasc Diabetol

Publication Year: 2024

DOI:
10.1186/s12933-024-02134-0

PMCID:
PMC10835902

PMID:
38302987

Journal Information

Full Title: Cardiovasc Diabetol

Abbreviation: Cardiovasc Diabetol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis study was approved by the institutional ethics committee of West China Hospital of Sichuan University. All enrolled patients signed the informed consent. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding The study has received funding by 1·3·5 project for disciplines of excellence–Clinical Research Incubation Project, West China Hospital, Sichuan University (Grant number ZYGD22013, ZYJC18003)."

Evidence found in paper:

"Trial registration Trial registration number: ChiCTR1800017058; URL: https://www.clinicaltrials.gov."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025